Lam Research Corporation (LRCX) Stock Analysis
Is LRCX a good investment?
Lam Research Corporation (LRCX) has a Plutrex AI rating of 79.0/100 as of November 04, 2026, indicating a Buy consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Historic profitability milestone with first-ever 40% operating margin and ROE of 70.1% (vs peer avg 55.5%) backed by $6.54B FCF — up 33.7% from prior report's $4.89B — confirming genuine competitive moat and superior capital efficiency not financial engineering. Main concern: Post-earnings selloff and analyst forecast cuts signal weaker forward guidance: headline 'Lam Research Analysts Cut Their Forecasts Following Q1 Earnings' and 9% stock drop despite record results ('Lam Research stock falls 9% despite record results') indicate management guided below street expectations — the market is pricing forward deceleration, not backward success.
Investment Summary
Lam Research (LRCX) at $230.72 represents a compelling entry point for a best-in-class semiconductor equipment franchise. The stock has declined another 12.4% since our prior Buy recommendation at $263.45, further improving risk/reward. Key financials: PE of 34.33x (down from 45.71x in our prior report — a 24.9% compression), PEG of 0.97 (below 1.0, down from 1.31 prior), ROE of 70.1% vs peer avg 55.5%, operating margin 40.0% (first-ever 40% OM quarter per headline 'Lam Research Just Posted Its First-Ever 40% Operating Margin'), FCF of $6.54B, cash of $7.44B, D/E of 0.27. Analyst consensus target of $361.12 implies 56.5% upside. The paradox: LRCX posted record Q1 results ($8.22B revenue vs $8.14B consensus), achieved a historic 40% operating margin milestone, yet the stock sold off 9% post-earnings (headline: 'Lam Research stock falls 9% despite record results'). This selloff — driven by analyst forecast cuts post-guidance (headline: 'Lam Research Analysts Cut Their Forecasts Following Q1 Earnings') — has created a materially better entry than our prior $260 midpoint. The bear case centers on weaker forward guidance and structurally below-peer-average growth (25.6% next year EPS vs 53.8% peer avg). The bull case: exceptional cash generation, dominant etch/deposition positioning, AI-driven capex tailwind, and a PEG below 1.0 for the first time in our coverage.
Key Strengths
- Historic profitability milestone with first-ever 40% operating margin and ROE of 70.1% (vs peer avg 55.5%) backed by $6.54B FCF — up 33.7% from prior report's $4.89B — confirming genuine competitive moat and superior capital efficiency not financial engineering
- Valuation transformation: PEG compressed from 1.31 to 0.97 (below 1.0 threshold) as stock declined 12.4% while PE fell 24.9% from 45.71x to 34.33x; analyst consensus $361.12 implies 56.5% upside vs. 40.2% in prior report — risk/reward has improved further
- AI structural tailwind with record foundry revenues: Q1 $8.22B beat consensus $8.14B for fifth consecutive quarterly record, demonstrating continued share gains in advanced node manufacturing essential for AI chip production
Key Concerns
- Post-earnings selloff and analyst forecast cuts signal weaker forward guidance: headline 'Lam Research Analysts Cut Their Forecasts Following Q1 Earnings' and 9% stock drop despite record results ('Lam Research stock falls 9% despite record results') indicate management guided below street expectations — the market is pricing forward deceleration, not backward success
- Persistent structural growth-valuation mismatch vs. peers: next-year EPS growth 25.6% is 52.5% below peer avg 53.8%, yet PE of 34.33x is 38.2% above peer avg 24.83x; PEG of 0.97 still 16.5% above peer avg 0.832 — LRCX remains relatively expensive per unit of forward growth versus semiconductor alternatives
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
LRCX's fundamentals are exceptional in absolute terms but mixed vs. semiconductor peers. PROFITABILITY: Gross margin 51.0% (vs peer avg 60.75% — the gap reflects capital equipment vs. fabless model, not weakness), operating margin 40.0% (a historic first, vs peer avg 52.97%), net margin 32.3% (vs peer avg 44.75%), ROE 70.1% (OUTPERFORMS peer avg 55.5% by 1,558bps — best-in-class capital efficiency). VALUATION: PE 34.33x (vs peer avg 24.83x — 38% premium), PEG 0.97 (below 1.0, but still 16.5% above peer avg PEG of 0.832). The PE premium is concerning relative to peers but the absolute PEG below 1.0 is attractive. GROWTH: Next-year EPS growth 25.6% vs peer avg 53.8% (52.5% deficit) — the most critical relative weakness; 5-year EPS growth 35.4% vs peer avg 60.5% (41% deficit). HEALTH: Cash $7.44B, FCF $6.54B (up from $4.89B in prior report — a material improvement), D/E 0.27 (vs peer avg 0.215 — marginally higher). Revenue growth 54.4% (up from 30% in prior report) confirms cycle acceleration. The fundamental picture: LRCX is an elite capital allocator (ROE 70%) with fortress finances ($7.44B cash, $6.54B FCF) trading below 1.0 PEG, but structurally lags peers on margins and growth — the market is correct to discount it vs. fabless peers but has arguably over-discounted given the 56.5% gap to analyst consensus. Additional metrics: PE Ratio: 34.33
News Sentiment
Lam Research just delivered one of the most confusing earnings reports in Silicon Valley history — smashing records while getting punished for it. The semiconductor equipment giant posted $8.22 billion in quarterly revenue, beating analyst expectations of $8.14 billion and marking its fifth straight record quarter. Even more impressive: the company achieved a 40% operating margin for the very first time in its history, a milestone most analysts didn't expect for another year or two. So why did the stock drop 9%? The answer lies in what comes next. Analysts from UBS, Deutsche Bank, JPMorgan, and Goldman Sachs — all of whom participated in the earnings call — walked away and quietly cut their forecasts. That's Wall Street's way of saying management's forward guidance didn't match the euphoria in the results. Despite all this, the company's fundamentals remain extraordinary: $7.44 billion in cash, $6.54 billion in annual free cash flow, and a dominant position in the etch and deposition equipment that every advanced chip factory — including those making AI processors — absolutely needs. Record foundry revenues confirm Lam is winning business from the world's most sophisticated chipmakers. One analyst even sees the stock doubling from current levels. The disconnect between spectacular results and a falling stock price is frustrating for existing shareholders but potentially a gift for patient investors. At current prices, the stock trades at a price-to-growth ratio below 1.0 — the threshold value investors consider a buy signal — with analyst targets averaging $361, implying 56% upside.
Risk Assessment
PRIMARY RISK: Weaker-than-expected forward guidance materialized in Q1 earnings (analyst cuts confirm this) — if semiconductor capex cycle decelerates in H2 2026/2027, consensus $361.12 target gets revised down further, potentially making current entry premature. MITIGATION: Stop at $205 (11% below entry midpoint $227.50) limits downside; at $205, PEG ≈ 0.86 — approaching peer avg PEG of 0.832, providing fundamental floor. SECONDARY RISK: Technical momentum remains impaired — stock has fallen from ~$290+ to $230.72 (-20%+) with no clear base yet; 'Lam Research stock falls 9% despite record results' suggests institutional selling on strength. MITIGATION: Entry range $220-$235 catches the post-earnings capitulation zone; phased entry (50% now, 50% at $215-220 if weakness continues) reduces timing risk. TERTIARY RISK: Peer relative underperformance — if semiconductor AI-driven names (fabless, HBM) continue to outperform LRCX's equipment cycle, capital rotation away from LRCX persists even if absolute fundamentals improve. MITIGATION: Position size capped at 3.5% (not 5%) until technical base confirmed. UPSIDE CATALYST: Recovery in memory capex guidance, AI chip manufacturer capex announcements, or any commentary suggesting 2027 equipment demand acceleration could re-rate stock sharply toward $300+.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is LRCX a halal stock?
Yes, Lam Research Corporation (LRCX) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for LRCX?
Lam Research Corporation (LRCX) has a Plutrex AI rating of 79.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is LRCX a good investment?
According to Plutrex AI, LRCX has a Buy rating (79.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in LRCX?
US stocks like LRCX can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in LRCX?
Plutrex AI identifies the main risks for LRCX by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.